Synapse Open Synapse
Biology

STAT+: Novartis multiple sclerosis treatment cuts rates of relapse in pivotal trials

STAT News · · 1 min read

An MS treatment from Novartis cut by a third the rates of relapses compared to a standard treatment.

Latest from STAT News